Found: 1
Select item for more details and to access through your institution.
Tailored pharmacokinetic dosing allows self-administration and reduces the cost of IV augmentation therapy with human α<sub>1</sub>-antitrypsin.
- Published in:
- European Journal of Clinical Pharmacology, 2003, v. 59, n. 2, p. 151, doi. 10.1007/s00228-003-0589-z
- By:
- Publication type:
- Article